Buscar
Mostrando ítems 1-10 de 180
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial
(Sage Publications, 2016)
Background: Embolic strokes of undetermined source comprise up to 20% of ischemic strokes. The
stroke recurrence rate is substantial with aspirin, widely used for secondary prevention. The New
Approach riVaroxaban ...
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial
(Sage Publications, 2016)
Background: Embolic strokes of undetermined source comprise up to 20% of ischemic strokes. The
stroke recurrence rate is substantial with aspirin, widely used for secondary prevention. The New
Approach riVaroxaban ...
The role of TCD in the evaluation of acute stroke
(Wiley, 2016)
BACKGROUND:
The additional information that transcranial Doppler (TCD) can provide as part of a multimodal imaging stroke protocol in the setting of hyper acute strokes has not been evaluated.
METHODS:
Consecutive ...
Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study
(Elsevier, 2013)
BACKGROUND:
Stroke mimics (SMs) are frequent in emergency departments (EDs), but are treated infrequently with intravenous recombinant tissue plasminogen activator (rt-PA) thrombolysis. We aimed at identifying the factors ...
Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study
(Elsevier, 2013)
BACKGROUND:
Stroke mimics (SMs) are frequent in emergency departments (EDs), but are treated infrequently with intravenous recombinant tissue plasminogen activator (rt-PA) thrombolysis. We aimed at identifying the factors ...
Long-term Adherence to National Guidelines for Secondary Prevention of Ischemic Stroke: A Prospective Cohort Study in a Public Hospital in Chile
(Elsevier, 2014)
Background Clinical guidelines for the secondary prevention of ischemic stroke have been developed, but their publication is insufficient to make them effective. Our aim was to investigate adherence to Chilean guidelines, ...
Long-term Adherence to National Guidelines for Secondary Prevention of Ischemic Stroke: A Prospective Cohort Study in a Public Hospital in Chile
(Elsevier, 2014)
Background Clinical guidelines for the secondary prevention of ischemic stroke have been developed, but their publication is insufficient to make them effective. Our aim was to investigate adherence to Chilean guidelines, ...
Thrombolysis for Acute ischemic Stroke with Recombinant Tissue Plasminogen Activator in a Chilean Public Hospital
(2011)
Background: The only accepted treatment for acute ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (t-PA). It was implemented in Chile in 1996, although its use was mainly restricted in Chile ...